We are live on ! Find out more
BLC

Brown, Lisle/Cummings Portfolio holdings

AUM $400M
1-Year Est. Return 18.79%
This Fund
S&P 500
This Quarter Est. Return
+6.78%
1 Year Est. Return
+18.79%
3 Year Est. Return
+61.76%
5 Year Est. Return
10 Year Est. Return
AUM
$329M
AUM Growth
+$22.2M
Cap. Flow
+$4.25M
Cap. Flow %
1.29%
Top 10 Hldgs %
27.78%
Holding
639
New
26
Increased
105
Reduced
112
Closed
19

Top Buys

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$960K
2
NOC icon
Northrop Grumman
NOC
+$739K
3
LHX icon
L3Harris
LHX
+$543K
4
MSFT icon
Microsoft
MSFT
+$541K
5
AMZN icon
Amazon
AMZN
+$488K

Sector Composition

Rank Sector Weight
1 Technology 17.12%
2 Healthcare 17.04%
3 Financials 13.36%
4 Industrials 10.47%
5 Communication Services 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
State Street SPDR S&P 500 ETF Trust
SPY
$782B
$13.9M 4.24%
24,308
-2,654
-10% -$1.47M
MSFT icon
2
Microsoft
MSFT
$2.85T
$12.9M 3.91%
29,868
+1,265
+4% +$541K
AAPL icon
3
Apple
AAPL
$4.9T
$11.4M 3.47%
48,944
-2,440
-5% -$545K
ICE icon
4
Intercontinental Exchange
ICE
$81.4B
$9.62M 2.92%
59,900
+2,850
+5% +$439K
ACN icon
5
Accenture
ACN
$88.9B
$8.13M 2.47%
23,006
+570
+3% +$187K
GOOGL icon
6
Alphabet (Google) Class A
GOOGL
$3.91T
$8.04M 2.44%
48,480
+965
+2% +$162K
AMZN icon
7
Amazon
AMZN
$2.51T
$7.96M 2.42%
42,695
+2,675
+7% +$488K
AMGN icon
8
Amgen
AMGN
$203B
$7.31M 2.22%
22,692
+485
+2% +$159K
BSX icon
9
Boston Scientific
BSX
$66B
$6.18M 1.88%
73,692
+75
+0.1% +$5.91K
NVO
10
Novo Nordisk
NVO
$217B
$5.98M 1.82%
50,195
+7,200
+17% +$960K
ABBV icon
11
AbbVie
ABBV
$457B
$5.55M 1.69%
28,091
+1,450
+5% +$271K
CNI icon
12
Canadian National Railway
CNI
$78.5B
$5.15M 1.57%
43,970
+1,400
+3% +$163K
META icon
13
Meta Platforms (Facebook)
META
$1.54T
$4.56M 1.38%
7,960
GOOG icon
14
Alphabet (Google) Class C
GOOG
$3.91T
$4.45M 1.35%
26,642
BRK.B icon
15
Berkshire Hathaway Class B
BRK.B
$1.07T
$4.39M 1.33%
9,545
-200
-2% -$88.4K
JPM icon
16
JPMorgan Chase
JPM
$937B
$4.3M 1.31%
20,414
-154
-0.7% -$32.4K
TMO icon
17
Thermo Fisher Scientific
TMO
$208B
$4.16M 1.26%
6,727
+300
+5% +$178K
FISV
18
Fiserv Inc
FISV
$27.3B
$4.16M 1.26%
23,150
BX icon
19
Blackstone
BX
$103B
$4.03M 1.22%
26,285
+225
+0.9% +$31.2K
TROW icon
20
T. Rowe Price
TROW
$24.9B
$3.96M 1.2%
36,345
-800
-2% -$87.8K
SUB icon
21
iShares Short-Term National Muni Bond ETF
SUB
$11.3B
$3.95M 1.2%
37,237
VEEV icon
22
Veeva Systems
VEEV
$30.1B
$3.89M 1.18%
18,523
-1,225
-6% -$242K
MRK icon
23
Merck
MRK
$324B
$3.66M 1.11%
32,187
+1,250
+4% +$149K
LHX icon
24
L3Harris
LHX
$55.9B
$3.47M 1.05%
14,585
+2,350
+19% +$543K
TXN icon
25
Texas Instruments
TXN
$256B
$3.31M 1%
16,006
+700
+5% +$141K

Similar funds

Brown, Lisle/Cummings's Q3 2024 Portfolio in Review

As of Q3 2024, Brown, Lisle/Cummings held 639 positions worth $329M, up 7.2% from $307M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Brown, Lisle/Cummings's Q3 2024 filing shows 26 new, 105 increased, 112 reduced and 19 closed positions. Its largest new stake was Avantis Emerging Markets Equity ETF: 1,266 shares worth $81.8K. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.47M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

  • Brown, Lisle/Cummings's largest Q3 2024 buy was Avantis Emerging Markets Equity ETF: 1,266 shares worth $81.8K.
  • Brown, Lisle/Cummings added most to Novo Nordisk in Q3 2024, an estimated $960K increase.
  • Brown, Lisle/Cummings's biggest Q3 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.47M.
  • Brown, Lisle/Cummings fully exited Lamb Weston in Q3 2024, selling an estimated $61.4K.
  • Brown, Lisle/Cummings's ten largest holdings make up 28% of its $329M portfolio in Q3 2024.
  • Brown, Lisle/Cummings opened 26 new positions and closed 19 in Q3 2024.
  • Brown, Lisle/Cummings's portfolio value rose 7.2% quarter-over-quarter to $329M.

Based on Brown, Lisle/Cummings's 13F filing for Q3 2024, filed 18 Oct 2024.